Healthy Volunteers Clinical Trial
Official title:
Long-Term Improvement in Training Effects by Transcranial DC Stimulation
| Verified date | December 16, 2013 |
| Source | National Institutes of Health Clinical Center (CC) |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
This study will examine whether continuous use of transcranial direct current stimulation
(tDCS) in combination with motor training can lead to long-term improvement in movement
performance beyond what can be achieved with motor training alone.
Healthy normal volunteers 18-80 years of age who are clearly right- or left-handed may be
eligible for this study. Each candidate is screened with a medical history, clinical and
neurological examination, questionnaires to evaluate memory, attention, and handedness and a
brain MRI, if one has not been done by NINDS within 12 months of entering the study. Pregnant
women may not participate.
The study involves 10 sessions (in addition to the screening visit) over 3 months. Sessions
1-5 are completed over 5 consecutive days. Sessions 6-10 are divided over the remaining time.
Participants are randomly assigned to one of three groups: 1) tDCS during motor training; 2)
tDCS after training; or 3) training with sham tDCS. During these sessions, participants
perform a pinch force task (squeezing a small device between the thumb and forefinger) and
visuomotor tasks (using a device to move the cursor on a computer screen to various targets
and holding the cursor in place for 1 second).
During the motor training and performance sessions, participants have the following
procedures.
- TMS measurements: A wire coil is held on the scalp, and a brief electrical current is
passed through the coil, creating a magnetic pulse that stimulates the brain. During the
stimulation, the subject may be asked to tense certain muscles slightly or perform other
simple actions. The stimulation may cause a twitch in muscles of the face, arm, or leg,
and the subject may hear a click and feel a pulling sensation on the skin under the
coil.
- tDCS: Small, wet sponge electrodes are applied to the head - one above the eye and the
other on the back of the head. A small electrical current is passed between them. The
subject may feel an itching or tingling sensation under the electrodes or see light
flashes. Some sessions are done with sham tDCS.
- Surface electromyography: Electrodes are filled with a conductive gel and taped to the
skin over one small hand muscle to measure the electrical activity of muscles.
- Behavioral measurements: Evaluation of learned movement tasks
- Questionnaires to evaluate the subject's attention, fatigue and mood before and after
testing
| Status | Completed |
| Enrollment | 196 |
| Est. completion date | December 16, 2013 |
| Est. primary completion date | |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years to 80 Years |
| Eligibility |
- INCLUSION CRITERIA: We will include HEALTHY VOLUNTEERS under the following circumstances: 1. Age of 18 to 80 years. 2. Written informed consent is given by the participant. 3. Mini-Mental-Status examination greater than 23 points. 4. Handedness as assessed by Edinburgh handedness inventory shows a laterality index (LI) greater than 75 (dexterity) or LI of less than -75 (left-handedness). 5. Ability to concentrate and to perform the tasks required in the present study. 6. Commitment to participate in the long-term follow-up (up to 3 months). We will include STROKE PATIENTS under the following circumstances: 1. Age of 18 to 80 years. 2. Stroke more than 3 months ago. 3. Single stroke with hemispheric lesions. 4. Stroke that affected one side of the brain (unilateral stroke). 5. Patients with initially severe motor paresis (below MRC grade 2), who subsequently recovered to the point that they have a residual motor deficit but still able to perform the tasks required by the study. 6. Commitment to participate in the long-term follow-up (up to 3 months). 7. Written informed consent is given by the patient. 8. Mini-Mental-Status examination greater than 23 points. 9. Handedness as assessed by Edinburgh handedness inventory shows a laterality index (LI) greater than 75 (dexterity) or LI of less than -75 (left-handedness). We will include TBI PATIENTS under the following circumstances: 1. Age of 18 to 80 years 2. Handedness as assessed by Edinburgh handedness inventory showing a laterality index (L1) greater than 75 (dexterity) or L1 of less than -75 (left-handedness) 3. Ability to concentrate on a computer task for up to an hour. 4. Ability to perform dominant hand thumb opposition against resistance. 5. Willingness to commit to the time involved in the study. 6. Willingness and ability to give consent. 7. TBI occurred from non-penetrating blunt, acceleration, or deceleration forces to the head. 8. TBI is of mild to moderate severity, based on loss of consciousness up to 24 hours, post-traumatic amnesia up to 7 days, or GCS score (9-15), as can be ascertained by medical records or patient report. 9. TBI more than 6 months ago EXCLUSION CRITERIA: We will exclude healthy volunteers and stroke patients, and TBI patients if one of the following conditions applies: 1. Unable to perform the tasks. 2. A history of severe neurological illness, e.g. brain tumor, epilepsy or a history of symptomatic seizures, polyneuropathy etc. 3. A history of severe alcohol or drug abuse, psychiatric illness such as severe depression, poor motivational capacity, or severe language disturbances, particularly of receptive nature or with serious cognitive deficits (defined as equivalent to a mini-mental state exam score of 23 or less). 4. More than moderate uncontrolled medical problems (e.g. active cancer or renal disease, any kind of end-stage pulmonary or cardiovascular disease, hypo/hyperthyroidism, severe diabetes, peripheral arteriopathy, or a deteriorated condition due to age, or other medical conditions as determined by the study physician, that would interfere with participation in this study). 5. Increased intracranial pressure as evaluated by clinical means (presence of papilledema in eye ground exam, compressed sulci/ventricle on MRI scan). 6. Metal in the body which might make having an MRI unsafe (e.g., vascular clips, cochlear implant) in the cranium (except in the mouth), pacemaker, implanted medication pumps, neural stimulators. 7. Drug treatment acting primarily on the central nervous system which lowers the seizure threshold such as antipsychotic drugs (chlorpromazine, clozapine) or tricyclic antidepressants (for the TMS component only). 8. Any visual disturbances, especially visual acuity less than 60%. 9. Diseased or damaged skin over the face or scalp. 10. Acute or chronic tendosynovitis, severe rheumatoid arthritis, active joint deformity of arthritic origin, according to the hand. 11. Professionally practiced playing a musical instrument or trained as a typist. 12. Pregnancy (for the MRI component only). EXCLUSION CRITERIA - FOR STROKE PATIENTS ONLY: 13. Both sides of the brain are affected by the stroke or clear bilateral motor impairment. EXCLUSION CRITERIA - FOR TBI PATIENTS ONLY: 14. TBI from penetrating gunshot or explosive trauma. 15. Post-traumatic seizures 16. No reported changes in both the Glascow Coma Scale and mental status following injury. 17. Active depression of any severity with psychoactive medication changes in the last 2 months. 18. Active psychosis, disruptive or violent behavior, or poor motivational capacity. 19. Pending litigation regarding the trauma |
| Country | Name | City | State |
|---|---|---|---|
| United States | National Institutes of Health Clinical Center, 9000 Rockville Pike | Bethesda | Maryland |
| Lead Sponsor | Collaborator |
|---|---|
| National Institute of Neurological Disorders and Stroke (NINDS) | Center for Neuroscience and Regenerative Medicine (CNRM), National Institutes of Health Clinical Center (CC), United States Department of Defense |
United States,
Bütefisch CM, Davis BC, Wise SP, Sawaki L, Kopylev L, Classen J, Cohen LG. Mechanisms of use-dependent plasticity in the human motor cortex. Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3661-5. — View Citation
Karni A, Meyer G, Rey-Hipolito C, Jezzard P, Adams MM, Turner R, Ungerleider LG. The acquisition of skilled motor performance: fast and slow experience-driven changes in primary motor cortex. Proc Natl Acad Sci U S A. 1998 Feb 3;95(3):861-8. Review. — View Citation
van Mier H, Tempel LW, Perlmutter JS, Raichle ME, Petersen SE. Changes in brain activity during motor learning measured with PET: effects of hand of performance and practice. J Neurophysiol. 1998 Oct;80(4):2177-99. — View Citation
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
| Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
| Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
| Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
| Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
| Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
| Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
| Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
| Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
| Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
| Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
| Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
| Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
| Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
| Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
| Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
| Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
| Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |